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The epithelial barrier at mucosal sites comprises an important mechanical protective
feature of innate immunity, and is intimately involved in communicating signals of
infection/tissue damage to inflammatory and immune cells in these local environments.
A wide array of antimicrobial factors (AMF) exist at mucosal sites and in secretions
that contribute to this innate immunity. A non-human primate model of ligature-induced
periodontitis was used to explore characteristics of the antimicrobial factor transcriptome
(n = 114 genes) of gingival biopsies in health, initiation and progression of periodontal
lesions, and in samples with clinical resolution. Age effects and relationship of AMF
to the dominant members of the oral microbiome were also evaluated. AMF could be
stratified into 4 groups with high (n = 22), intermediate (n = 29), low (n = 18) and
very low (n = 45) expression in healthy adult tissues. A subset of AMF were altered in
healthy young, adolescent and aged samples compared with adults (e.g., APP, CCL28,
DEFB113, DEFB126, FLG2, PRH1) and were affected across multiple age groups. With
disease, a greater number of the AMF genes were affected in the adult and aged samples
with skewing toward decreased expression, for example WDC12, PGLYRP3, FLG2,
DEFB128, and DEF4A/B, with multiple age groups. Few of the AMF genes showed a >2fold increase with disease in any age group. Selected AMF exhibited significant positive
correlations across the array of AMF that varied in health and disease. In contrast, a rather
limited number of the AMF significantly correlated with members of the microbiome;
most prominent in healthy samples. These correlated microbes were different in younger
and older samples and differed in health, disease and resolution samples. The findings
supported effects of age on the expression of AMF genes in healthy gingival tissues
showing a relationship to members of the oral microbiome. Furthermore, a dynamic
expression of AMF genes was related to the disease process and showed similarities
across the age groups, except for low/very low expressed genes that were unaffected in
young samples. Targeted assessment of AMF members from this large array may provide
insight into differences in disease risk and biomolecules that provide some discernment
of early transition to disease.
Keywords: non-human primate, aging, microbiome, periodontitis, antimicrobial factors
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INTRODUCTION

features of AMF responses that would be correlated with certain
bacteria or clusters/complexes of bacteria.

The oral mucosa is a critical protective interface between
external and internal environments and serves as a barrier to
the myriad of microbial species in the oral microbiome. Due
to the inherent structure where hard tissues (i.e., teeth) break
through an intact epithelial barrier, this anatomical region is one
where there is a significant risk of bacterially induced infection
and inflammation.
To help manage this continual septic environment, a diverse
family of antimicrobial factors is produced, which defend the oral
cavity and other mucosal surfaces of the body. The oral cavity
is home to the second-most diverse microbiome in humans,
and the health of the mouth is influenced by the presence of
autochthonous bacteria, as well as by intrinsic and extrinsic
host factors. Prior to the evolution of adaptive immunity, innate
immunity played a role as the principal defense system. The
innate immune system augmented the physical and chemical
barriers by producing antimicrobial biomolecules (antimicrobial
factors; AMF) with functionality against Gram-positive and
negative bacteria, parasites, fungi, and viruses [1–3]. Thus,
these factors, as a first line of defense, have multiple functions
and properties that influence aspects of innate defenses and
contribute to regulation of colonization by microorganisms.
The host expresses these protective molecules from immune
and non-immune cells that are released into the local
environment to act rapidly to combat invasion and infection with
bacteria and other microorganisms. Oral epithelial cells, salivary
glands and neutrophils secrete a wide profile of antimicrobial
gene products detected in gingival crevicular fluid and saliva
[2, 4–9]. Many of these AMFs are also highly concentrated in
GCF providing a local microenvironment enriched in factors
to help control the supra- and subgingival microbiomes [1,
3, 10]. Nevertheless, mechanistic considerations of this system
support that the antimicrobial capacity of oral fluids permits
and even enhances colonization of the oral cavity by various
microorganisms, but prevents extensive microbial overgrowth of
the oral and oropharyngeal tissues.
The mechanism of action of these AMFs against microbes
and pathogens is attributed to the disruption of the microbial
cell membrane [11–13], competition for nutrients [14–16], and
microbial aggregation and mechanical or biological removal
[17–19]. Also of importance is evidence regarding substantial
variation between different species of oral bacteria and even
strains of the same species in susceptibility to individual AMFs,
such as LL-37 (CAMP) and hBD3 [1, 20–22]. In particular, major
pathobionts including P. gingivalis, A. actinomycetemcomitans
and F. nucleatum have shown relative resistance to some of these
AMFs [23–26]. Thus, documenting the portfolio of the AMFs
that are produced/released under different stimuli, as well as
modulating influences (e.g., smoking, diabetes, nutrition etc.)
will help in understanding the variation in disease expression,
progression, and risk for periodontal diseases [13, 20].
The aim of this study was to map the gingival tissue AMF
profile to determine alterations in disease and lesion resolution,
as well as the impacts of age on this profile. The hypothesis of
this study was that the gingival tissues would present an AMF
expression profile with patterns affected by age and with specific
Frontiers in Oral Health | www.frontiersin.org

MATERIALS AND METHODS
Animals and Diet
Rhesus monkeys (Macaca mulatta) (n = 36; 17 male, 19 female)
housed at the Caribbean Primate Research Center at Sabana
Seca, Puerto Rico were examined for periodontal health [27–
29] and were used to determine the results from a ligatureinduced periodontitis model. Young (≤3 years); adolescent (3–7
years); adult (12–16 years); and aged (18–23 years) were used
in the study with 9 animals/group. The non-human primates
were fed a 20% protein, 5% fat, and 10% fiber commercial
monkey diet (diet 8773, Teklad NIB primate diet modified:
Harlan Teklad, Madison, WI). The diet was supplemented with
fruits and vegetables, and water was provided ad libitum in an
enclosed corral setting.
As we have reported previously the protocol was approved by
the Institutional Animal Care and Use Committees (IACUC) of
the University of Puerto Rico and University of Kentucky and a
ligature disease model was utilized [30]. The clinical examination
included probing pocket depth (PPD) and bleeding on probing
(BOP; 0–5 scale) [31]. Periodontal health was defined by mean
Pocket Depth (PD) ≤3.0 mm and mean Bleeding on Probing
(BOP) ≤1 (0–5 scale) in a full mouth examination excluding 3rd
molars and canines [30]. Ligature-induced periodontal disease
was initiated as we have previously reported [30] and gingival
and subgingival plaque samples taken at 0.5, 1, and 3 months
(Initiation/Progression), and 2 months after removal of ligatures
and local factors (Resolution). Determination of periodontal
disease at the sampled site was documented by assessment of
the presence of BOP and probing pocket depth of >4 mm, as
we have described previously [28]. Changes in these clinical
measures of BOP and PPD in health, during disease initiation
and progression, and with resolution in these age groups have
been described previously [32]. Briefly, all animals demonstrated
significant increases in BOP within 0.5 months, with somewhat
elevated levels in the younger age groups. PPD increases were
noted in all animals across all age groups with peak disease
at 1 or 3 months. However, in both young and adolescent
animals, the PPD measures for rate of change and peak levels
of disease were less than in the adult and aged group. At
resolution, both BOP and PPD measures decreased across all
age groups, albeit generally remaining above measures for the
baseline, healthy tissues.

Microbiome Analysis
Subgingival bacterial samples were obtained from the 36 animals
by a curette and analyzed using a MiSeq instrument [33, 34]
for the total composition of the microbiome from each sample
[35, 36]. Sequences were clustered into phylotypes based on
their sequence similarity and these binned phylotypes were
assigned to their respective taxonomic classification using the
Human Oral Microbiome Database (HOMD V13) (http://
www.homd.org/index.php?name=seqDownload &file&type=R)
as we have described previously [33]. Raw data were deposited
at the NIH NCBI (BioProject ID PRJNA516659). Statistical
2
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neuropeptides and receptors, and various transcription factors
that demonstrated consistent directional changes, albeit, the
magnitude of change was frequently somewhat greater with the
qPCR [40–43].
Clustering analysis was conducted that included analysis of 18
AMF genes. A parametric t-test (α = 0.05) was used to identify
the differentially expressed genes and bacteria at 0.5, 1, 3, and
5 months using baseline expression as control. Those that were
differentially expressed, in at least at one of the time points in
one or more age groups, were identified and entered into this
analysis to examine clustering of both age groups and disease
time points. The Principal Components Analysis (PCA) plot was
created from results generated with BioVinci software (BioTuring
Inc.). Transcript data of the 18 AMF genes that had high variance
scores from PCA analysis were averaged across all animals in the
same age category. Gene expression data was used to create the
unrooted dendrogram by calculating the distance matrix with
the Euclidean method followed by ward D2 linkage clustering
method using the Ape package in R version 4.1.1. The data
was normalized on a scale of 0 to 1, with the lowest value set
at 0 and the highest value at 1, to generate the heatmap and
rooted dendrogram for the cluster analyses. The agglomerative
hierarchal cluster analyses were performed by calculating the
distance matrix using the Squared Euclidean method and by
average linkage (between-group) clustering method using SPSS
v27 (IBM).

differences of bacterial OTUs were determined with a t-test
(p < 0.05). Correlations of OTUs within the oral microbiome
were determined using a Pearson correlation coefficient analysis
(p < 0.05). Correlations between the microbiome components
and the gingival gene expression were determined only for
matching samples derived from the same tooth in each of the
animals. Matching samples with sufficient microbiome signals
were compared for 46 samples in adults and 25 samples from
the young group obtained at health and throughout the ligature
model. As we have reported previously [33], of 396 OTUs
identified in the non-human primate oral samples the targeted
OTU selection for this study was 49 in the young/adolescent
samples and 58 in the adult/aged samples with a relative
abundance coverage of ∼88% and ∼91% of reads in all samples.

Gingival Tissue Sample Collection and
mRNA Analysis
Gingival tissue samples of healthy and diseased sites were
surgically collected and total RNA extracted for microarray
analysis. The analytic hybridization was to the GeneChip R
Rhesus Gene 1.0 ST Array (Affymetrix, Santa Clara, CA, USA)
for the ligature-induced periodontitis model similar to methods
we have described previously [27, 28, 37–39].

Data Analysis
Genes for the array of the innate antimicrobial factors (n =
114) targeted in the analysis as identified in Table 1. Beyond the
specific Affymetrix probe annotation provided by the company,
we annotated within the GeneChip R Rhesus Gene 1.0 ST
Array additional probes for the host genes in this microarray.
These included unannotated probes, whereby the nucleotide
base sequence (https://www.affymetrix.com/analysis/index.affx#
1_2) for each probe ID was subjected to a Blast (https://blast.ncbi.
nlm.nih.gov/Blast.cgi) query that identified the M. mulatta gene
ID with the greatest percent identify for the specific sequence.
We selected the most targeted gene ID that always showed >90%
identity and routinely >95% identity for annotating the gene list
for the analysis.
The expression intensities across the samples were estimated
using the Robust Multi-array Average (RMA) algorithm with
probe-level quintile normalization, as implemented in the Partek
Genomics Suite software version 6.6 (Partek, St. Louis, MO).
The differential expression was initially compared using one way
ANOVA across time points within an age group. For genes that
had significant mean differences, two sample t-tests were used to
investigate differences comparing baseline healthy to disease and
resolution samples. Statistical significance was considered by a pvalue <0.05 adjusted for the number of correlations tested using
a Benjamini-Hochberg procedure. The data have been uploaded
into GEO accession GSE180588 (https://www.ncbi.nlm.nih.gov/
gds). Correlation analyses were determined using a Pearson
Correlation Coefficient with a p-value <0.05 and adjusted for the
number of correlations tested. Frequently a qPCR technique is
used as a validation step for microarray outcomes. While we did
not incorporate this approach into the analysis of this large array
of AMF genes, we have previously published the use of qPCR to
validate 28 genes from the larger microarray dataset including
inflammatory cytokines and chemokines, apoptosis genes, and
Frontiers in Oral Health | www.frontiersin.org

RESULTS
Age Effects on Innate Antimicrobial Factor
Gene Expression in Healthy Gingival
Tissues
The normalized expression of transcripts for the 114 innate
antimicrobial factors is demonstrated in Figure 1 with the genes
stratified into high (n = 22), intermediate (n =29), low (n = 18),
and very low (n = 45) expression based upon the healthy/baseline
adult gingival specimens. In healthy/baseline gingival tissues,
generally there were some observed differences in expression
based upon age, including variations in both younger and aged
animal samples. For example, DEFB4A/B, LTF, and TF were all
decreased in the younger age groups, while CST6 (cystatin E/M),
DEFB126, DEFB105/A/B, S100A7, and DEFB106A/B were lower
in all age groups compared to adult levels. Figure 2 displays
volcano plots of the AMF genes that were altered in young,
adolescent, and aged samples compared to the adult levels in
health. Seventeen genes were 2-fold and/or significantly different
(p < 0.01) in the young animals. Fewer gene differences were seen
in adolescent samples (n = 8), while 8 of the genes differed in the
aged animals. Of note, APP, CCL28, DEFB113, DEFB126, FLG2,
and PRH1 were differentially expressed in healthy gingival tissues
across multiple age groups.

Age Effects on Innate Antimicrobial Factor
Gene Expression in Progressing
Periodontitis
Supplementary Figures 1A–D depict the alterations in
transcript levels for the array of antimicrobial factor genes
3
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TABLE 1 | Affymetrix Rhesus GeneChip 1.0 probes and gene IDs.
Probe ID

Gene ID

Product

Probe ID

Gene ID

Product

13657000

ADM

Adrenomedullin

13607401

CST7

Cystatin 7

13726537

APP

Amyloid beta precursor protein

13607369

CST8

Cystatin 8

13690380

AZU1

Azurocidin 1

13613078

CST9

Cystatin 9

13771401

B2M

Beta-2-macroglobulin

13817566

CST9L

Cystatin 9-like

13611789

BPIFB1

BPI Fold Containing Family B Member 1

13703548

CSTA

Cystatin A

13611309

BPI (CAP57)

Bactericidal Permeability Increasing Protein

13725659

CSTB

Cystatin B

13611807

BPIFA1

BPI Fold Containing Family A Member 1

13607358

CSTL1

Cystatin Like 1

13611830

BPIFA2

BPI Fold Containing Family A Member 2

13783258

CTSG

Cathepsin G

13611813

BPIFA3

BPI Fold Containing Family A Member 3

13664108

CTSL

Cathepsin L

13611823

BPIFA4P/LATH

BPI Fold Containing Family A Member 4

13625511

DCD

Dermcidin

13611885

BPIFB2

BPI Fold Containing Family B Member 2

13790332

DEFA1/MNP1A

Defensin Alpha 1

13611856

BPIFB3

BPI Fold Containing Family B Member 3

13833190

DEFA3

Defensin Alpha 3

13611841

BPIFB4

BPI Fold Containing Family B Member 4

13786263

DEFA4

Defensin Alpha 4

13611870

BPIFB6

BPI Fold Containing Family B Member 6

13786265

MNP2/DEFA5

Defensin Alpha 5

13614378

BPIFC

BPI Fold Containing Family C

13790317

DEFA6

Defensin Alpha 6

13649823

CALCA

Calcitonin Related Polypeptide Alpha

13790306

DEFB1

Defensin Beta 1

13712310

CAMP

Cathelicidin Antimicrobial Peptide

13786259

DEFB4A/B

Defensin Beta 4A/B

13766180

CCL28

C-C Motif Chemokine Ligand 28

13786254

DEFB103A/B

Defensin Beta 103A/B

13777140

CHGA

Chromogranin A

13786233

DEFB104A/B

Defensin Beta 104A/B

13613073

CST11

Cystatin 11

13790341

DEFB105A/B

Defensin Beta 105A/B

13607382

CST2

Cystatin 2

13786229

DEFB106A/B

Defensin Beta 106A/B

13613082

CST3

Cystatin 3

13790338

DEFB107A/B

Defensin Beta 107A/B

13826456

CST4

Cystatin 4

13786278

DEFB108B

Defensin Beta 108B

13613088

CST5

Cystatin 5

13746694

DEFB110

Defensin Beta 110

13654297

CST6

Cystatin 6

13746691

DEFB113

Defensin Beta 113

13746688

DEFB114

Defensin Beta 114

13672583

LPO

Lactoperoxidase

13612123

DEFB115

Defensin Beta 115

13706136

LTF

Lactotransferrin

13606458

DEFB116

Defensin Beta 116

13619325

LYZ

Lysozyme

13612117

DEFB118

Defensin Beta 118

13797016

MBL2

Mannose Binding Lectin 2

13612111

DEFB123

Defensin Beta 123

13756581

MUC7

Mucin 7, Secreted

13606439

DEFB124

Defensin Beta 124

13735015

NPY

Neuropeptide Y

13606465

DEFB126

Defensin Beta 126

13593402

PADI2

Peptidyl Arginine Deiminase 2

13606469

DEFB127

Defensin Beta 127

13581278

PADI4

Peptidyl Arginine Deiminase 4

13612140

DEFB128

Defensin Beta 128

13610899

PI3/SKALP

Peptidase Inhibitor 3

13606475

DEFB129

Defensin Beta 129

13821042

PGLYRP1

Peptidoglycan Recognition Protein 1

13786281

DEFB130A

Defensin Beta 130A

13599233

PGLYRP3

Peptidoglycan Recognition Protein 3

13786284

DEFB131A

Defensin Beta 131A

13599241

PGLYRP4

Peptidoglycan Recognition Protein 4

13786287

DEFB134

Defensin Beta 134

13593639

PLA2G2A

Phospholipase A2 Group IIA

13790347

DEFB135

Defensin Beta 135

13751874

PPBP (CXCL7)

Pro-Platelet Basic Protein

13786290

DEFB136

Defensin Beta 136

13796562

PRF1

Perforin 1

13798980

DMBT1

Deleted In Malignant Brain Tumors 1

13648572

PRG2/BMPG

Proteoglycan 2, Pro Eosinophil Major Basic Protein

13672570

EPX

Eosinophil Peroxidase

13817862

PRH1

Proline Rich Protein HaeIII Subfamily 1

13660411

FCN1

Ficolin 1

13616577

PRH2

Proline Rich Protein HaeIII Subfamily 2

13665140

FCN2

Ficolin 2

13774182

RNASE7

Ribonuclease A Family Member 7

13594266

FCN3

Ficolin 3

13599250

S100A12

S100 Calcium Binding Protein A12

13753483

FGF2

Fibroblast Growth Factor 2

13599267

S100A7

S100 Calcium Binding Protein A7

13599193

FLG2

Filaggrin Family Member 2

13599257

S100A8

S100 Calcium Binding Protein A8

13636114

FN1

Fibronectin 1

13587085

S100A9

S100 Calcium Binding Protein A9

13696432

GALP

Galanin Like Peptide

13801212

SFTPA1

Surfactant Protein A1

13818738

GNLY

Granulysin

13796073

SFTPD

Surfactant Protein D

13693567

HAMP

Hepcidin Antimicrobial Peptide

13605622

SLPI

Secretory Leukocyte Peptidase Inhibitor
(Continued)
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TABLE 1 | Continued
Probe ID

Gene ID

Product

Probe ID

Gene ID

Product

13738591

H2AC6

H2A Clustered Histone 6

13611542

SPAG4

Sperm Associated Antigen 4

13744613

HSBC4

H2B Clustered Histone 4

13735408

TAC1

Tachykinin Precursor 1

13713258

HRG

Histidine Rich Glycoprotein

13714939

TF

Transferrin

13611295

LBP

Lipopolysaccharide Binding Protein

13748448

VIP

Vasoactive Intestinal Peptide

13665108

LCN1

Lipocalin 1

13605627

WFDC12

WAP Four-Disulfide Core Domain 12

13762706

LEAP2

Liver Enriched Antimicrobial Peptide 2

FIGURE 1 | Normalized expression values for antimicrobial factors categorized as high, intermediate, low and very low expression levels based upon the adult healthy
tissues. Each point denotes mean value from 9 animals/group. The genes are sequenced based upon the expression level in adult samples.

comparing baseline healthy levels to initiation (0.5 months),
progression (1 and 3 months) and resolution (5 months) of
periodontal lesions. Examination of fold differences showed
a limited number of changes in the highly expressed genes in
the young and adolescent animals. A greater number of these
genes were affected in the adult and aged samples with skewing
toward decreased expression of these genes across all age groups.
WDC12, PGLYRP3, and DEF4A/B were decreased in disease
across multiple age groups. Supplementary Figure 1B shows the
differential expression of the intermediate expressed transcripts

Frontiers in Oral Health | www.frontiersin.org

for these factors. Consistent findings were decreased FLG2,
DEFB128, and increased levels of CTSL and LTF with disease.
Low expression genes are shown in Supplementary Figure 1C
with no differences in any of the genes in young animals. PADI4
and FCN1 were increased in the other groups, and DEFB126,
DEFB113, DEFB106A/B, DEFB110, DEFB127, and DEFA6, were
all decreased in the adult samples. Supplementary Figure 1D
summarizes the differences in very low expression AMF genes
compared to baseline healthy levels in the age groups. Minimal
differences were noted in adolescent, adult and aged samples. A

5
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FIGURE 2 | Volcano plots of differential AMF gene expression levels in health tissues from various age groups compared to healthy adults. Each point represent the
mean value from 9 animals at baseline.

of these also decreased in the young and adolescent samples
during disease. As the repertoire of genes selected for this study
were primarily related to epithelial cell biology, the distribution
of the decreased AMF in the older groups versus young samples
inferred that the more destructive disease process in the adult
and aged animals was reflected in the apparent disruption of the
breadth of AMF responses designed to maintain homeostasis.
Figures 4A,B examined the concept that there could exist
coincident programming and responses across these AMF genes
in health and disease. In each case, a rather limited number
of correlations across this array of AMF were noted in healthy
tissue in any age group, suggesting a rather independent control
of these responses to the local microbiome during health. In
contrast, there were many more extensive correlations in gene
expression across the AMF factors during disease. Interestingly,
the frequency of these correlations increased from young through
aged animals in the disease samples. Additionally, the pattern of
these relationships was striking in the aged animals with a large
frequency of significant positive correlations across a wide range
of the AMF.

number of the AMF appeared decreased in the young samples
with disease, albeit, these did not attain a 2-fold difference from
baseline expression levels.
Figure 3 summarizes the antimicrobial factor genes that were
significantly altered in the different age groups with disease and
resolution. The data demonstrate 30 (young) and 12 (adolescent)
AMF genes that were increased with FN1, PGLYRP3, ADM,
CTSL, LTF, FLG2, and DEFB115 being represented in both these
age groups. Of these AMF genes, BPIFC, FLG2, and multiple
DEFB genes were decreased in expression with disease in one
or both young and adolescent animals. A similar evaluation of
these differences in the adult and aged animals is also displayed.
First, the number of the affected transcripts was only about 40%
of those in the youngest animals. Secondly, about 60% of these
genes were significantly decreased in both age groups. Increased
FN1, CTSL, ADM, PADI4, and FCN1 was noted in the adult and
the aged groups, as well as most being elevated in the younger
animal groups. Decreased levels of expression of multiple genes
including DEFB4A/B, PGLYRP3, BPIFC, WFDC12, PI3/SKALP,
DEFB128 were observed in adults and aged samples, with many

Frontiers in Oral Health | www.frontiersin.org
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FIGURE 3 | Array of AMF genes that were significantly (p < 0.05) differentially expressed at least at one time point during disease and resolution in tissues from the 4
age groups. Bars denote mean fold-difference from baseline at each time point. Genes are organized into expression level categories based upon Figure 1.

and adolescent animals were all in the same general root
structure, while progressing disease (i.e., 1 and 3 month) for the
adults and aged animals grouped together. Finally, the disease
initiation AMF profiles (i.e., 2 weeks) in the adult and aged
samples showed some unique features compared to all other
disease specimens.
While oral bacteria clearly trigger the destructive
inflammatory responses of periodontitis, substantial literature
has identified an array of host factors that could directly account
for the features of inflammation, soft tissue destruction, and
alveolar bone resorption in this disease. As such, we asked the
question regarding the relationship between the expression of
AMF genes and targeted host genes associated with the local
environmental tissue changes in the periodontium. Figure 6
presents the data identifying the frequency of significant
correlations in AMF and the genes that could impact the
environment and tissues. The striking feature was the much
higher frequency of these relationships in the younger animals
compared to the older adult/aged group in both health and

Figure 5 provides a visualization of the relationship among
the various AMFs related to both age and health/disease
of the gingival tissues. The emphasis of the cluster analysis
and heatmap is for 18 of the AMF genes that showed
distinct expression differences across the age groups and
related to the stage of health, disease, and resolution of the
gingival tissues. This analysis identified 5 clusters with the
primary grouping based upon stage of disease, with age as
a secondary feature. Additionally, similarities in expression
were noted between baseline and resolution specimens. The
figure also provides a Principal Components Analysis using
the same set of genes. This analytic approach also identified
5 groups of expression and also demonstrated disease as
the primary feature controlling the AMF expression patterns.
Finally, Figure 5 also summarizes these same linkages in an
unrooted tree structure. Features show the profiles of AMF
expression are quite similar in healthy and resolution samples,
albeit the health samples from adult and aged animals were
somewhat unique. Secondly, the disease samples in the young
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Figure 7B for the older group of animals. While there were many
similarities in the microbial distribution during different stages
of disease, a striking change was the increase in Porphyromonas,
Fusobacterium, and Fretibacterium with disease in the older
animal samples.
Figure 8 demonstrates the overall relationship between the
microbial burden (total bacterial signal readout) and the
normalized signal for the microarray values for the entire set
of AMFs. The results showed the microbial burden increased
with disease in both age groups; however, the levels returned
to near baseline in the older group of animals (AD/AG),
while remaining increased by nearly 60% in the Y/ADO group.
However, the pattern of general AMF gene expression was
quite different in the 2 age groups. The levels at baseline were
significantly greater in the AD/AG group, but decreased with
disease initiation and progression. In the Y/ADO group, the AMF
levels increased at the early stages of disease. Both age groups
showed AMF gene levels approximating baseline values in the
resolution samples.

disease. Also apparent was the large number of these correlations
in the younger groups during disease.

Oral Microbiome Components and Innate
Antimicrobial Factor Gene Expression in
Health and Disease
The oral microbiome in humans and non-human primates
is quite complex, with many similarities in the distribution
of phyla, genera, and species [44–46]. As it is clear that
an array of host factors, including the AMFs interact with
components of the microbiome, we examined details of these
potential relationships. Figure 7A displays the distribution of the
various primary genera of bacteria within the oral microbiome
of samples from the younger animals. Substantial changes
occur with disease initiation (0.5 months) that are generally
retained during disease progression and remain quite distinct
from the healthy microbiome even with clinical resolution of
disease (5 months). A similar profile of genera is provided in

FIGURE 4 | Continued
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FIGURE 4 | Correlations among the AMF gene in (A) young and adolescent health and disease and (B) adult and aged health and disease. The bars denote the
number of either positive or negative significant correlations for each of the genes showing 5 or more significant correlations across the entirety of the 114 AMF group
examined. Genes are organized into expression level categories based upon Figure 1 (h, high; i, intermediate; l, low; vl, very low).

samples from the adult/aged group, with a limited number
of AMF genes showing any correlations with the microbiome
components, and only CST9, DEFB126, DEFB127, and S100A7
demonstrating an elevated number of correlations.
The data was also evaluated to identify the members of the
oral microbiome that dominated in correlations with the array
of AMF gene expression patterns in the juxtaposed gingival
tissues. Figure 10A shows multiple OTUs that were highly
correlated with the AMF in healthy young/adolescent samples
that included Leptotrichia_unclassified, Prevotella_unclassified,
Capnocytophaga_unclassified, Bacteroidetes_unclassified, P.
gingivalis HMT619, SR1_[G-1] sp. HMT345, E. infirmum
HMT105, Prevotella sp. HMT313, T. socranskii HMT769, P.
intermedia HMT643, and Leptotrichia sp. HMT223. In disease,
these correlations were much more limited with none of the
bacteria demonstrating >15 correlations. In contrast, in the
resolution samples, 8 OTUs showed an elevated frequency of
correlations with the AMF gene expression levels and included
Treponema_unclassified,
Capnocytophaga_unclassified,
T.

Figure 9 shows the relationship between the AMF gene
expression levels and correlations with the array of OTUs
in the microbiome samples. We included 49 OTUs that
comprised readouts accounting for 77–86% in the younger
group and 58 OTUs representing 74–82% in the older group.
In healthy samples from the younger group (Figure 9A), we
identified that CST5, DEFA3, DEFB128, DEFB131A, GALP,
MBL2, TF, WFDC12, BPIFA4P, and PI3/SKALP showed elevated
frequencies of significant correlations. The frequency of AMFmicrobial relationships decreased substantially during disease
with only FN1 represented. In the resolution samples, while fewer
transcripts were significantly correlated, DCD, DEFB103A/B,
DEFB129, S100A12, WFDC12, BPIFA3, and BPIFA4P all showed
extensive correlations across the various OTUs. Figure 9B
provides a comparison with the adult/aged group samples with 21
genes demonstrating frequent correlations (>10) in the healthy
tissues samples. As noted in the younger samples, this was
decreased to only PRG2 and LEAP2 in the disease samples.
A contrast with healthy tissues was observed in the resolution
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FIGURE 5 | (A) Heatmap and clustering using 18 AMF genes that discriminated age and the disease process. (B) Principal Components Analysis of 18 AMF genes.
Y, young; O, Adolescent; U, Adult; G, Aged samples; b, baseline; 2, initiation; 1 and 3, progression; 5, resolution of disease. Each point denotes the mean of the age
group and time point. (C) Unrooted tree representation of grouping of the AMF gene expression. Labels are as in (B).

samples. We then determined the AMF gene levels based upon
the ratio of high/low levels of the microbial families. Most
notable was that across the bacteria, the majority of the AMF
were increased with lower relative abundance of the various
bacterial families. In particular, expression of WFDC12, PBPP,
CST5, BPIFC, DEFB103A, PI3/SKALP, SLPI, LTF, and DEF4A/B
were most broadly impacted by showing decreased levels with
higher levels of multiple families of bacteria in the microbiome.
Additionally, Lactobacillales, Pasteurellales, Selenomonadales,
and Veillonellales demonstrated the greatest frequency of lower
expression with the higher relative abundance in the samples.

denticola HMT584, SR1_[G-1] sp. HMT345, Fusobacterium sp.
HMT203, Prevotella sp. HMT304, and T. socranskii HMT769.
Figure 10B summarizes the microbial components with
numerous AMF correlations in the adult/aged group
samples. In the healthy samples, 24 OTUs showed a large
number of significant correlations to the AMF transcripts.
A different subset of these were seen in disease, highlighted
by Fusobacterium_unclassified, Fretibacterium sp. HMT361,
S. sputigena HMT151, P. gingivalis HMT619, Porphyromonas
sp. HMT279, P. enoeca HMT600, T. maltophilum HMT664,
F. fastidiosum HMT363, G. morbillorum HMT046, Desulfobulbus
sp. HMT041, Haemophilus sp. HMT035, and M. catarrhalis
HMT833. Finally, in the resolution samples, this magnitude of
correlations was generally absent in the adult/aged samples.
Supplementary Figure 2 presents a summary of the AMF
genes that are most greatly affected by components of
the microbiome. In this analysis, the bacterial families that
predominated in the microbiome were stratified into high and
low levels based upon median family level in the adult/aged
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Microbial Complexes and Inflammatory
Gene Expression in Aging
A pattern of microbiome members and specific groups of the
AMF were noted within these individual correlation analyses.
This pointed to a feature, in which there appeared complexes
of the bacteria that related to a particular profile of the AMF,
potentially related to their general or specific antimicrobial

10

March 2022 | Volume 3 | Article 817249

Ebersole et al.

Oral Microbiome and Gingival Responses

FIGURE 6 | Correlations between AMF gene expression levels and various groups of genes related to the tissue microenvironment in younger (Y/ADO) and older
(AD/AG) animal gingival tissues. Colors denote number of significant positive or negative correlations of each tissue gene with the array of AMF genes.

features. Figure 11A provides a profile of the characteristics of
these complexes related to patterns of AMF expression. First
of note was that two bacterial complexes in healthy younger
samples primarily showed positive correlations with the AMF,
while YH/AMF2 was skewed toward negative correlations with
the AMF. The complexes were represented by unique individual
microbiome features, with the members comprised of a mix
of species that are classically considered more pathogenic and
others identified as commensal. With disease, the members of
the complexes changed with YD/AMF1 and YD/AMF2 oriented
more toward pathogenic species and YD/AMF3 generally
considered commensals. This difference was noted with the
relative correlation distribution of the complexes to the AMF.
In the adult/aged samples, AdH/AMF1 and AdH/AMF3
showed more dominant positive correlations with the AMF. Of
interest was that AdH/AMF1 demonstrated a prevalence of what
would be considered pathogenic species, while AdH/AMF3 was
generally commensals. In contrast AdH/AMF2 and AdH/AMF4
showed dominant negative correlations with AdH/AMF2
showing mostly more pathogenic species. Substantial changes
were observed in the complexes in the adult/aged disease
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samples. AdD/AMF2 and AdD/AMF5 showed a high prevalence
of negative correlations with the AMF and AdD/AMF2 was
highly represented by more pathogenic species. In contrast,
AdD/AMF3 showed almost entirely significant positive
correlations with the AMF, and was composed of species
generally considered as commensals.
Figure 11B provides a tabulation of the individual AMF
that displayed the predominance of correlations to the various
bacterial complexes. First, 103 of the AMF showed significant
correlations to one or more of the bacterial complexes.
Secondly, specific complexes demonstrated enhanced numbers of
these correlations including YH/AMF1, YH/AMF2, AdH/AMF1,
AdH/AMF4, AdD/AMF3, and AdD/AMF4. Within the young
healthy samples only 10–15% of the individual AMF actually
overlapped between the two complexes and all were in an
opposite correlation direction. Fewer specific correlations were
noted in the young disease samples with unique AMF patterns
for each complex and with only BPIFC, CST5, DEFA3, DEFB128,
PRH1, and TF showing an elevated frequency of correlations.
The four complexes in the adult/aged samples also showed low
overlap of AMF (1–8 AMF similar), while the disease samples
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FIGURE 7 | Relative abundance of various genera of bacteria within the microbiomes of (A) younger (Young/Adolescent) or (B) older (Adult/Aged) gingival tissues.
Each ring represents one sampling time point. Red arrow denotes starting point for identification of individual genera.

immune response in this environment and are produced by
epithelial cells, polymorphonuclear leukocytes, and salivary
gland cells to contribute to protection of the oral cavity with
overlapping and unique functions. Beyond the direct bacterial
effects including affecting microbial viability, and functions of
bacterial LPSs and peptidoglycans, many AMFs possess host cell
regulatory functions including apoptosis, proinflammatory, and
chemotactic activities. Various studies have identified alterations
in AMFs in the oral cavity of humans with periodontitis [49–
55], as well as demonstrating the capacity of various oral bacteria
to trigger production of these biomolecules from various cells
in culture. However, generally these studies have focused on
one or a few of the innate immune components related to

exhibited even less overlap (1–3 AMF similar). The AMF genes
that demonstrated the greatest prevalence of correlations in these
older animal samples included BPIFB2, CHGA, CST4, DEFA1,
DEFB107A, DEFB126, HRG, PPBP, and S100A12.

DISCUSSION
Antimicrobial factors (AMFs) in the oral cavity range from
the relatively large agglutinating mucins to ion scavenging
molecules, to smaller membrane-perforating cationic peptides
[2, 13, 47, 48]. These AMFs are important contributors to
maintaining the balance between health and disease in this
complex environment. These AMFs are part of the host innate
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FIGURE 8 | Box and whisker plot of total abundance of the bacterial signals in samples from younger and older animal groups at baseline, with disease, and in
resolution samples. Similar plot tabulated the sum of the microarray normalized signals for all AMFs in each sample.

show more significant dysbiotic changes with the disease process.
Nevertheless, there was extensive overlap in the targeted AMF
genes that were affected in all age groups.
The detection of overlapping AMF expression features
within the samples across age groups suggested the potential
for distinctive correlation patterns of AMF. Exploring these
correlations in healthy tissues showed a somewhat limited
frequency of significant correlation across the array of AMFs.
Young and adolescent animals displayed ∼20% of the AMF
genes with numerous correlations, while 30% of the genes
showed high correlations in the adults and nearly 50% of the
genes were highly correlated in the aged samples. This was
somewhat unexpected, as both innate and adaptive immune
responses are generally negatively associated with the aging
process. However, it appears that many of the AMFs may be
conserved during aging, and show an increased similarity in
regulation of expression. Also, of note in this dataset was that
previous reports indicated that the antimicrobial factor changes
in saliva did not appear to cluster around similar functions for
the biomolecules, but showed diverse properties including LPSbinding protein (LBP) altered coupled with cystatins, lipocalin
1, and perforin 1 [56, 57]. Here the array of altered AMFs
could be assigned to multiple functional targets and may more
broadly reflect changes in the microbiome, to which various
host cells are responding. A striking feature of the AMF gene
expression patterns was exposed when examining the clustering
of the AMF expression in gingival tissues from the various
age groups, and in health and disease. Our previous results

health and disease [9]. This study mapped the relative abundance
of 114 AMF genes in non-human primate gingival tissues in
health, disease and resolution, as well as the effect of age on
this expression. Moreover, this expression was examined related
to the presence of the major 50–60 bacterial OTUs in the oral
microbiome, and the relationship to genes expressed in the
tissues that indicate local environmental features in the gingiva.
Of the AMF characterized in the study, expression levels
in healthy tissues demonstrated various AMFs expressed at
high to very low levels. Comparing the expression across age
showed a limited number of these genes differed, albeit, some
unique features were displayed in both young and aged animals,
e.g., CST6, CTSL, CAMP, DEFB126, CCL28. Additionally, the
number of the AMF genes that differed significantly from adult
levels were routinely greatest in samples from young animals,
with an overlap of about 50% of the differentially expressed genes
across the age groups. Extension of the determination of the
AMF expression focused on changes related to disease initiation
and progression, as well as in tissues with clinically resolved
lesions. Again, nearly twice as many of the AMFs were altered
in the young samples vs. the other age groups. While most of
these differences were identified in disease samples, a subset of
the AMF remained altered even in the resolution samples. Also,
in the young and adolescent groups 60–70% of the genes were
upregulated during disease, while nearly? were down-regulated
in the adult and aged animals. This observation could be related
to a more resilient oral microbiome that we described before in
aging vs. young animals. As such, the young animals appeared to
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using single cell RNASeq studies provides a method to explore
the cellular composition in complex tissues and uses specific
mRNA patterns to describe the tissue composition [63]. Related
to this, various approaches have been used to explore existing
large gene expression datasets to also document the character of
the cellular makeup of tissues. The approach uses cell-specific
convolution and a computation method of population-specific
expression analysis (PSEA) to describe the cell composition
[64–66]. Specifically, Momen-Heravi et al. [67] has recently
reported on the use of this technique to characterize the cellular
composition of human gingival tissues in health and disease.
The AMF data was extracted from a larger microarray study
that is amenable to this type of bioinformatics exploration and
should add insights into the changes in cellular composition that
underpin these AMF gene alterations in disease. An additional
focus can also be generated from the breadth of findings in
this study such that hypothesis generation can be developed
based upon the more detailed findings of individual AMF and
their potential molecular role in homeostasis and/or disease. An
example of this concept is in the findings with ficolin (FCN1)
that was generally significantly positively related to the disease
process. The ficolins are soluble pattern recognition molecules
that contribute to complement activation via the lectin pathway

have supported that the transition from health to disease was
a major driving feature of altered gingival gene expression
patterns for multiple pathways [27, 30, 37, 38, 40, 41, 58–62].
While some age differences were observed, the major changes
appeared to be disease related. In a similar fashion with the
AMF, cluster analysis clearly emphasized that the characteristics
of the gingival tissues (i.e., health, disease, resolution) appeared
to be the major controlling factor in the relationship of AMF
expression. This suggested that evolution of the AMF producing
pathways was similar with aging processes. These biomolecules
are a downstream expression of numerous molecular pathways of
innate immunity. Thus, some common features of cell receptors,
cellular signaling, or transcription and translation processes
may be under similar control in aging, more than previously
considered. Identification of these regulatory components should
provide improved insight into alterations in host resistance to
infection, neoplasia, and even autoimmunity that could occur
with aging. As noted since the AMFs represent an array of
biomolecules with various cellular origins within the gingival
tissues, an understanding of the temporal cellular differences
during disease initiation and resolution would add additional
knowledge to the features of the specific cellular responses
that occur and result in alter AMF levels. Current technology

FIGURE 9 | Continued
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FIGURE 9 | Significant positive or negative correlations between relative abundance of the 49 OTUs (A) in the younger group or 58 OTUs (B) in the older group
included in the microbiome analysis and individual AMF genes. Bars denote number of OTUs correlated with the specific AMF gene. Only AMF genes with significant
correlations with 5 or more of the microbial OTUs are included.

[68]. Ficolins in serum are complexed with MBL-associated
serine proteases and bind to carbohydrates present on the
surface of microbes as components of innate immune responses.
Related to periodontitis, studies have shown that LPS-induced
inflammation can induce a significant ficolin response [69].
While the ficolin response/function has very limited findings
in periodontitis studies have shown that the mirolysin of T.
forsythia degrade these AMF and alter complement aspects
of innate immunity [70]. Additionally, through its interaction
with complement, one could propose an important role due to
the clear data implicating complement activation and disease
associated with P. gingivals [71–73].
Clear data demonstrate that exposure of gingival epithelial
cells to oral bacteria that have been associated with periodontitis
results in the production of an array of innate immune
molecules, including β-defensins and CAMP (LL-37) [2].
Furthermore, the importance of the array of AMFs have been
supported by a number of genetic disorders associated with
decreased AMF production in the oral cavity, and increased
susceptibility to bacterial infections [2, 74, 75]. Additional
examples include mucin-7 and lactoferrin being significantly
altered in patients with periodontitis [76]. Thus, we evaluated
the relationship of this array of AMFs with expression of
genes that would reflect a changing periodontal environment
that would contribute to tissue alterations consistent with a
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disease process. The results showed few correlations between
the AMF levels and the expression of the various tissue and
environmental genes in the older group of animals. However,
numerous significant correlations were observed in the younger
group that were most noted in disease samples, and displayed
generally positive correlations with inflammatory genes and
significant negative correlations with the bone biology, tissue
destructive/remodeling, and hypoxia genes. The numerous
correlations were unexpected, but may reflect a more regulated
response capacity of the gingival tissues in the younger group,
which is consistent with less destructive disease [42].
It is also clear that the characteristics of the oral microbiome
in the subgingival sulcus that is juxtaposed to the gingival tissues
shows interactions that are critical for homeostasis. However,
alterations toward a dysbiotic microbiome occur with disease
and are reflected by substantial gene expression changes in the
tissues. We have previously described the microbiome at sites
of periodontal lesions in the non-human primates and how
these differ in healthy and resolved lesion samples [33, 77–79].
The microbiome data presented distinct differences in samples
from younger and older animals, as well as changes in the
microbial distribution with disease in the younger group of
animals. Interestingly, at the level of the 26 dominant microbial
genera, the changes were more subtle in samples from the older
animals with Fretibacterium the most distinctive of the changes.
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however, one interpretation is that with tissue homeostasis these
AMF represent a family of genes that are responsive to the
oral microbiome and may help regulate homeostasis. During
disease this relationship is substantially decreased potentially
reflecting the dysbiosis and host dysregulation, or being driven
by members comprising the new dysbiotic microbiome. An
additional question was also addressed regarding the biologic
features of healthy tissues and gingival tissues that represent
resolved lesions. The data showed a clear difference in AMF
expression in healthy compared to disease resolved tissues in both
age groups, with the greatest loss of relationships in the resolution
samples from the older animals.
A previous study focused on an array of antimicrobial peptides
(AMPs) that showed a wide variation between individuals and
were modulated by disease [50]. The results suggested salivary
AMPs present in periodontal health and disease showed some
correlations of specific antimicrobial peptides and clusters of
these AMPs with bacterial species and clusters of species in
the oral microbiome. Our results drilled down to individual
OTU/species level and explored these relationships with the

This relatively recently identified genera within the phylum
Synergistetes has been identified in multiple studies as a potential
microbial diagnostic marker of disease [80–82]. Moreover, it was
identified as a member of a group of microbes that remained
elevated in persistent aggressive disease patients post-therapy
[83, 84]. Thus, the findings in this non-human primate model are
reflective of the disease microbiome in humans.
The data was then interrogated to estimate relationships
among specific microbial components of the microbiome and
the patterns of AMF expression in the tissues. In both groups
of animals, frequent significant correlations across a wide
range of the AMF were observed in the healthy samples,
with 20–25% greater frequency of positive correlations. In
contrast, during disease ∼40–50% fewer correlations were
noted, although in both age groups the positive relationships
dominated. Finally at resolution, while the positive and negative
correlation frequencies were similar in both the age groups,
the striking feature was the lower number of AMF genes that
contributed to these correlations. There is a general lack of
comparable literature with which to compare these findings;

FIGURE 10 | Continued
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FIGURE 10 | Significant positive or negative correlations between individual AMF genes and relative abundance of specific OTUs (A) in the younger group or (B) in the
older group. Bars denote number of AMF correlated with the specific OTU.

broader AMF gene levels in health, disease and resolution. In
health, the portfolio of individual bacteria showed 54 and 73%
with elevated correlations in the younger and older groups,
respectively. The microbial representation of the correlations
with AMF was decreased greatly during disease, with only 4
OTUs in the younger group and only 30% of the bacteria
in the older group samples, although these were comprised
of Fusobacterium, Bacteroidetes, Porphyromonas, Prevotella,
Treponema, Fretibacterium, and Chloroflexi genera. Similarly,
a substantial difference in the correlation patterns between
the bacteria and AMF was seen in the younger vs. the older
animal resolution samples. The samples from the younger
animals appeared to re-establish the AMF-bacterial correlations
in resolution samples, while these were totally lost in the older
animal specimens.
Finally, as periodontitis reflects changes in the geospatial and
functional aspects of microbial complexes in the subgingival
microbiome [85–88] we explored the presence of microbial
consortia and estimated their combined role in regulating the
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AMF patterns with age and in health and disease. We had
previously reported on these types of microbial consortia that
were significantly associated with gingival tissue responses of
apoptosis, autophagy and hypoxia genes [77, 78]. Additionally,
we identified other microbial complexes in the microbiome
of young and older animals that related to the expression of
an array of immunoglobulin genes in the gingival tissues (in
press). Thus, we identified multiple microbial complexes in the
young and older animal samples that significantly correlated
with a group of the AMF in health and disease. The features
of these complexes identified clearly different complexes in the
young and older animal samples in both health and disease.
Individual complexes in the young animals showed a skewing
toward either positive or negative correlations with the AMF in
health or disease. In contrast, there was a distinct predilection for
individual complexes to exhibit positive or negative correlation
with the array of AMF. The complexes also demonstrated a
prevalence of more pathogenic species, mostly commensals, or
a mixture of these species within the same complex. Finally,
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FIGURE 11 | (A) Relative distribution of positive and negative correlations across the AMF genes related to specific bacterial complexes in young (Y) or older (Ad)
animals samples. Complexes are identified in healthy samples (e.g., YH, AdH) or diseased samples (e.g., YD, AdD). (B) Correlations between microbiome complexes
and individual AMF gene levels. The red box denotes significant positive correlations and the black denotes significant negative correlations with the array of bacteria
in the identified complex.
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there was generally limited overlap in the specific AMF that
correlated with these complexes within health or disease samples
in either age grouping. These results supported, as was observed
with the relationship to apoptosis, autophagy, hypoxia and
immunoglobulin genes, somewhat distinct patterns of microbial
complex relationships to these host AMF responses, which
underpins certain host-microbe interactions that may be critical
for the maintenance of gingival homeostasis or can reflect a basis
for the transition to a disease process. Further work remains
to better understand the detailed temporal nature of these
interactions and potential utilization for these parameters for
estimating risk of disease progression or more limited response
to standard therapy.
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